Live Bending Spoons Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about

Akari Therapeutics Plc

AKTX

Latest SEC Filings from Akari Therapeutics Plc

  1. 1
    1

    Akari Therapeutics Reports $4.8 Million Net Loss and Faces Liquidity Challenges in Latest Filing

    via official filing (AI summary) 2 months ago 0 comments
  2. 2
    1

    Akari Therapeutics Reports $14.5 Million Net Loss and Financial Challenges in Latest 10-Q

    via official filing (AI summary) 5 months ago 0 comments
  3. 3
    1

    Akari Therapeutics Reports $17.3 Million Net Loss for Fiscal Year 2025, Focuses on ADC Platform Development

    via official filing (AI summary) 7 months ago 0 comments
  4. 4
    1

    Akari Therapeutics Reports $6.4 Million Net Loss in Q3 2025, Shifts Focus to ADC Platform

    via official filing (AI summary) 11 months ago 0 comments
  5. 5
    1

    Akari Therapeutics Reports $1.9 Million Net Loss in Q2 2025, Down from $7.6 Million Last Year

    via official filing (AI summary) about 1 year ago 0 comments
  6. 6
    1

    Akari Therapeutics Reports $3.7 Million Net Loss, Focuses on Antibody-Drug Conjugate Platform

    via official filing (AI summary) over 1 year ago 0 comments
  7. 7
    1

    Akari Therapeutics Reports $19.8 Million Net Loss for 2024 Amid Strategic Shift and Merger

    via official filing (AI summary) over 1 year ago 0 comments
  8. 8
    1

    Akari Therapeutics Reports Significant Financial Challenges, Losses, and Doubt Over Going Concern

    via official filing (AI summary) almost 2 years ago 0 comments